4-((4-(aminomethyl)pyridin-2-yl)oxy)cyclohexan-1-one oxalate, 95.0%, 250mg

Flacon à col moyen 307, 1000 ml, 50 mm, 4 pièce(s)

(3,5-Dichlorophenyl)(2,4,6-trimethoxyphenyl)iodonium 4-methylbenzenesulfonate, 98%, 5g

3-Chloro-3-phenyl-1,3-dihydroindol-2-one, 97%, 100mg

3-Hydroxybutanamide, 98%, 5g

(3-Bromo-5-methoxyphenyl)boronic acid, 95.0%, 1g

2-Chloro-1-(3-hydroxyazetidin-1-yl)ethan-1-one, 95.0%, 5g

8-Fluoroquinazoline-2,4(1H,3H)-dione, 95.0%, 10g

1-Bromo-4-phenylnaphthalene, 95.0%, 1g

1-(4-Bromo-3-nitrophenyl)ethanone, 95.0%, 10g

7-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDAZOLE, 95.0%, 500mg

3-Phenylisoxazole-5-carbaldehyde, 95.0%, 5g

(1-Methyl-1H-indol-3-yl)methanamine, 95.0%, 1g